Press Releases

Innovative Products from Green Valley were Displayed at the Exhibition Commemorating the 40th Anniversary of China's Reform and Opening-up
Date:2018-12-07

For forty years, we've marched forward regardless of hardship or remarkable achievements. It has been the Reform and Opening-up that has made China a truly powerful nation. Recently, "The Great Revolution – A Large Exhibition Commemorating the 40th Anniversary of China's Reform and Opening-up" was held at the National Museum of China. Salvianolate, the milestone product that marked the modernization of Traditional Chinese Medicine (Green Valley participated in the R&D and commercialization  of this drug), as well as GV-971, the world's first oligosaccharide drug against Alzheimer's disease invented in China (the phase III clinical trial for this drug was successfully completed this year), were both displayed as China's key innovative products. These leading edge medications were shown in the exhibition area titled "Great National Power - Technological Innovation Helps China Fulfill the Dream of Becoming a Powerful Country." This exhibition reflects China's recognition and acknowledgement of the two key innovative drugs. 

11.jpg


12.jpg

"The Great Revolution - A Large Exhibition Commemorating the 40th Anniversary of China's Reform and Opening-up" was hosted by the Publicity Department of the CPC Central Committee, Reform Office of the CPC Central Committee, Institute of Party History and Literature of the CPC Central Committee, the National Development and Reform Commission, Ministry of Commerce, etc. It is aimed at displaying extraordinary achievements made during China's Reform and Opening-up. This is especially true of the historical achievements made and revolutions since the 18th CPC National Congress. Up until now, more than 50 million people have visited the exhibition.

For more than 20 years, Green Valley has kept growing in a fertile environment that favors innovation under the policies of the Reform and Opening-up.Green Valley has kept up with the, as of yet, unsatisfied demand for treatment solutions for complex chronic diseases, targets at core technologies in the development, and production of carbohydrate drugs. Green Valley has carried out long-term strategic cooperative agreements with top-tier research institutes, colleges, and universities in China including the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. It has also promoted the industry application of research results for many Chinese innovative drugs.

Salvianolate Injection: An innovative drug that can significantly improve myocardial circulation. It has been used in more than 5,000 Chinese hospitals and clinical practices. It has brought remarkable health benefits to more than 20 million patients with coronary artery disease and coronary microvascular disease. 




13.jpg


GV-971: A marine-derived oligosaccharide. It shows encouraging results from its phase III clinical trial. ( Read More )



14.jpg


A new chapter is being written in this new era. Facing a new round of a global technology revolution and a change in China's developmental mode, Green Valley understands its responsibilities as a Chinese pharmaceutical enterprise that sticks to innovation. Facing rare opportunities and challenges, Green Valley will continue to innovate and prove the innovative capabilities of Chinese pharmaceutical companies. Green Valley will undertake missions with practical actions. It will help promote the construction of a healthy China and cope with global health challenges and opportunities with Chinese wisdom. It will spare no effort to provide Chinese health solutions to patients with complex chronic diseases worldwide.


ShareTo:
Previous Page:
Green Valley was Awarded “Excellent Expert Academician Workstation of 2018 in Pudong New District"
Next Page:
Paying Tribute to the "Star Scientists" Who Are Forging Ahead in the New Era!